Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes
Open Access
- 1 June 2009
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 50 (6), 1216-1222
- https://doi.org/10.1194/jlr.p800070-jlr200
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Serial Measurements of Cystatin C Are More Accurate Than Creatinine-Based Methods in Detecting Declining Renal Function in Type 1 DiabetesDiabetes Care, 2008
- Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular RiskJAMA, 2008
- Development of an immunoblot assay with infrared fluorescence to quantify paraoxonase 1 in serum and plasmaJournal of Lipid Research, 2008
- New Predictive Equations Improve Monitoring of Kidney Function in Patients With DiabetesDiabetes Care, 2007
- The development of human sera tests for HDL-bound serum PON1 and its lipolactonase activityJournal of Lipid Research, 2007
- Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?Free Radical Biology & Medicine, 2004
- Paraoxonase 1 192Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitusDiabetic Medicine, 2004
- Low paraoxonase activity in type II diabetes mellitus complicated by retinopathyClinical Science, 2000
- A Polymorphism of the Paraoxonase Gene Associated With Variation in Plasma Lipoproteins in a Genetic IsolateArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976